Established in 2020, Glopex® co., Ltd is fast growing in the global aesthetic market, aiming to be a developer and manufacturer of biomedical and biopharmaceutical products and services in the global market.

Glopex®‘s main business area not only focuses on the biomedical field, but we are also setting our first steps to advance in medicine-based biotechnologies to improve overall global health.

With continuous in-house research and development, we plan to develop different types of advanced hyaluronic acid gels, botulinum toxins, and other biomedical and biopharmaceutical products with our exclusive technologies.